Herbert Lyerly
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer (NCT04270149) | Herbert Lyerly | 2020-09-01 |
| HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies (NCT03906643) | Herbert Lyerly | 2020-07-15 |
| Assessing the Immunogenicity of pING-hHER3FL (NCT03832855) | Herbert Lyerly | 2020-07-13 |
| A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer (NCT03632941) | Herbert Lyerly | 2019-03-01 |
| A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies (NCT03333031) | Herbert Lyerly | 2018-08-10 |
Track Herbert Lyerly automatically
Every clearance here is in the API, with alerts when new ones post.